BioCardia Inc (BCDA)
2.94
+0.18
(+6.52%)
USD |
NASDAQ |
Sep 27, 16:00
2.91
-0.03
(-1.02%)
Pre-Market: 20:00
BioCardia Revenue (Annual): 0.477M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.477M |
| December 31, 2022 | 1.352M |
| December 31, 2021 | 1.015M |
| December 31, 2020 | 0.145M |
| December 31, 2019 | 0.71M |
| December 31, 2018 | 0.625M |
| December 31, 2017 | 0.479M |
| December 31, 2016 | 0.576M |
| December 31, 2015 | 0.517M |
| December 31, 2014 | 0.427M |
| December 31, 2013 | 0.268M |
| December 31, 2012 | 0.062M |
| December 31, 2011 | 0.012M |
| December 31, 2010 | |
| December 31, 2009 |
| Date | Value |
|---|---|
| December 31, 2008 | 1.268M |
| June 30, 2008 | |
| June 30, 2007 | |
| June 30, 2006 | |
| June 30, 2005 | |
| June 30, 2004 | |
| June 30, 2003 | 4.078M |
| June 30, 2002 | 3.957M |
| June 30, 2001 | 3.866M |
| June 30, 2000 | 3.988M |
| June 30, 1999 | 4.20M |
| June 30, 1998 | 3.90M |
| June 30, 1997 | 3.40M |
| June 30, 1996 | 3.148M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
0.145M
Minimum
2020
1.352M
Maximum
2022
0.7398M
Average
0.71M
Median
2019
Revenue (Annual) Benchmarks
| Alnylam Pharmaceuticals Inc | 1.828B |
| Theriva Biologics Inc | -- |
| Zevra Therapeutics Inc | 27.46M |
| PetIQ Inc | 1.102B |
| Instil Bio Inc | -- |